BNXT
BNXT

BioNxt Solutions Inc.

Status
Active
Issued & Outstanding110,519,065
Reserved for Issuance11,777,150
Currency
CSE Index

About

BioNxt Solutions Inc.

Listing date
July 31, 2019

BioNxt Solutions Inc. is a bioscience accelerator focused on next-generation drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical production and evaluation, including: precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications. The Company has research and development operations in North America and Europe, with an operational focus in Germany, and is currently focused on regulatory approval and commercialization of medical products for European markets.